ORN0829
short T1/2 dual orexin 1/2 receptor antagonist in clinical dev. for insomnia (Ph. II) from ligand-based drug design Bioorg. Med. Chem., Apr. 11, 2020 Taisho Pharmaceutical Co., Saitama, JP
Molecules of the Month - April 2020
Molecules of the Month
- tucatinib
- S6821
- MRTX849
- BAY1161909
- ORN0829
- BMS-986251
- GSK2818713
- CPI-1612
- “Compound 19”
- AZD4205
- QPX7728
- “Compound 9”
- “Compound (P)-14″
- FT385